Biomea Fusion, Inc.

BMEA

Biomea Fusion, Inc.

BMEA

Insider Sentiment (TTM):

Last Purchase:2025-12-11Last Sale:2023-06-01Shares Purchased (TTM):140,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:24,133,565Shares Outstanding:72,299,440Institutional Ownership Pct.:33.38%

Earnings Market Reaction:

Filing Date:2026-05-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Biomea Fusion, Inc. (BMEA) — SEC Financial Statements & Analysis

Biomea Fusion, Inc. (BMEA) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Cash And Cash Equivalents At Carrying Value	45	56	47	56	36	58	88	113	145	177	199	223
Assets Current
Assets Current	46	58	49	65	45	68	94	116	148	179	203	226
Prepaid Expense And Other Assets Current	1	2	3	8	9	10	6	3	3	2	3	3
Restricted Cash Current	0	-	-	-	-	-	-	-	-	-	-	-
Property Plant And Equipment Net	0	0	0	3	3	4	4	4	5	5	6	6
Restricted Cash	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets Noncurrent	-	0	0	0	1	1	5	7	7	6	5	4
Operating Lease Right Of Use Asset	-	0	5	5	6	7	8	8	9	10	12	13
Restricted Cash Noncurrent	0	-	-	-	-	-	-	-	-	-	-	-
Assets	46	59	55	73	55	80	110	136	168	200	225	249
Liabilities And Stockhold…
Accounts Payable Current	5	3	6	8	8	13	9	6	5	7	3	4
Liabilities Current
Liabilities Current	9	11	16	18	20	22	28	25	25	23	16	14
Operating Lease Liability Current	1	1	1	1	1	2	3	3	3	2	3	3
Operating Lease Liability Noncurrent	0	0	6	6	7	7	7	7	8	8	9	10
Liabilities	28	29	40	46	26	28	34	32	33	31	25	24
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	480	479	469	465	445	439	434	429	423	418	414	410
Stockholders Equity
Stockholders Equity	19	30	16	28	29	52	76	104	135	169	200	224
Retained Earnings Accumulated Deficit	-461	-449	-454	-437	-417	-387	-358	-325	-288	-249	-214	-186
Liabilities And Stockholders Equity	46	59	55	73	55	80	110	136	168	200	225	249
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	300	300	300	300	300	300	300	300	300	300	300	300
Common Stock Shares Issued	72	72	60	58	38	36	36	36	36	36	36	36
Shares Outstanding	72	72	60	58	38	36	36	36	36	36	36	36

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-19.11%	-10.19%	-	-	-	-	-	-	-	-	-	-
2025	-28.00%	-9.50%	-8.50%	23.42%	32.91%	-7.59%	-13.49%	4.76%	6.35%	95.58%	19.47%	3.54%
2024	-7.80%	-55.91%	-57.75%	36.62%	55.12%	109.16%	-46.60%	-64.93%	-67.04%	2.82%	-30.52%	-15.02%
2023	-	-	-	-27.06%	-34.29%	-51.33%	-5.24%	29.39%	25.86%	-27.42%	-18.13%	-62.27%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	4.98	5.23	3.18	3.68	2.25	3.15	3.39	4.62	5.84	7.84	12.49	15.74
Quick Ratio	4.85	5.03	3.00	3.20	1.81	2.69	3.19	4.50	5.74	7.74	12.28	15.53
Working Capital	37.02M	46.95M	33.88M	47.10M	24.87M	46.66M	66.03M	91.13M	122.31M	156.32M	186.29M	211.58M
Leverage & Debt
Debt to Equity	1.48	0.98	2.53	1.66	0.92	0.55	0.45	0.31	0.25	0.18	0.13	0.11
Debt Ratio	0.60	0.50	0.72	0.62	0.48	0.35	0.31	0.24	0.20	0.15	0.11	0.10
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-0.62	-1.18	-1.60	-2.76	-3.51	-3.83	-3.98	-3.87	-3.55	-3.44	-3.02	-2.89
Free Cash Flow Per Share TTM	-0.78	-1.35	-1.45	-2.47	-3.11	-3.33	-3.12	-3.09	-2.93	-2.93	-2.75	-2.57
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-65.05%	-55.36%	-33.54%	-19.73%	1.07%	18.06%	33.73%	36.72%	34.65%	43.29%	51.19%	67.62%
EPS Growth (1Y)	-82.30%	-69.14%	-59.78%	-28.80%	-0.96%	11.52%	31.64%	34.08%	11.00%	22.98%	24.33%	38.45%
Valuation Metrics
P/E TTM	-2.46	-1.05	-1.26	-0.65	-0.61	-1.01	-2.54	-1.16	-4.22	-4.22	-4.56	-7.60
P/B	5.91	2.19	7.74	2.66	2.71	2.72	4.82	1.56	3.97	2.93	2.46	3.46
Market Cap	110.62M	64.76M	120.89M	73.13M	78.02M	140.09M	365.83M	162.20M	536.56M	495.23M	490.60M	775.90M
Enterprise Value	65.56M	8.95M	73.88M	16.54M	41.78M	81.81M	277.51M	48.54M	391.64M	318.37M	291.51M	552.64M
Calculated Values
Free Cash Flow TTM	-56.37M	-70.37M	-86.52M	-100.37M	-113.86M	-120.26M	-113.02M	-111.55M	-105.08M	-99.96M	-98.03M	-90.94M
Net Debt	-45.06M	-55.81M	-47.01M	-56.59M	-36.23M	-58.28M	-88.32M	-113.66M	-144.92M	-176.87M	-199.09M	-223.26M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-12-11Purchase

Owner: Erdtmann, Rainer M

Title: See Remarks

Shares: 30,000

Price/Share: $1.43

Value: $42,900.00

Shares Owned: 723,027

Relationship: Director,Officer

Ownership: Direct

2025-12-02Purchase

Owner: Hitchcock, Michael J.M.

Title: Interim CEO

Shares: 100,000

Price/Share: $0.99

Value: $99,000.00

Shares Owned: 115,000

Relationship: Director,Officer

Ownership: Direct

2025-12-01Purchase

Owner: Erdtmann, Rainer M

Title: See Remarks

Shares: 10,000

Price/Share: $1.05

Value: $10,500.00

Shares Owned: 693,027

Relationship: Director,Officer

Ownership: Direct

2024-09-30Purchase

Owner: Hitchcock, Michael J.M.

Title: -

Shares: 10,000

Price/Share: $10.06

Value: $100,600.00

Shares Owned: 15,000

Relationship: Director

Ownership: Direct

2024-06-11Purchase

Owner: Valle, Franco

Title: Chief Financial Officer

Shares: 12,509

Price/Share: $4.43

Value: $55,414.87

Shares Owned: 42,500

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-12-11	Erdtmann, Rainer M	Director,Officer	See Remarks	Direct	Purchase	30,000	1.43	$42,900.00	723,027	4
2025-12-02	Hitchcock, Michael J.M.	Director,Officer	Interim CEO	Direct	Purchase	100,000	0.99	$99,000.00	115,000	4
2025-12-01	Erdtmann, Rainer M	Director,Officer	See Remarks	Direct	Purchase	10,000	1.05	$10,500.00	693,027	4
2024-09-30	Hitchcock, Michael J.M.	Director	-	Direct	Purchase	10,000	10.06	$100,600.00	15,000	4
2024-06-11	Valle, Franco	Officer	Chief Financial Officer	Direct	Purchase	12,509	4.43	$55,414.87	42,500	4
2023-06-01	A2A, Pharmaceuticals, Inc…	TenPercentOwner	-	Direct	Sale	50,000	34.56	$1,728,000.00	3,500,000	4
2023-05-12	A2A, Pharmaceuticals, Inc…	TenPercentOwner	-	Direct	Sale	25,000	33.84	$846,000.00	3,625,000	4
2023-05-09	A2A, Pharmaceuticals, Inc…	TenPercentOwner	-	Direct	Sale	150,000	34.50	$5,175,000.00	3,650,000	4
2023-04-20	A2A, Pharmaceuticals, Inc…	TenPercentOwner	-	Direct	Sale	200,000	29.12	$5,824,000.00	3,900,000	4
2023-03-31	A2A, Pharmaceuticals, Inc…	TenPercentOwner	-	Direct	Sale	200,000	31.25	$6,250,000.00	4,100,000	4/A
2023-03-30	Cormorant, Global Healthc…	TenPercentOwner	-	Indirect	Purchase	400,000	30.00	$12,000,000.00	3,570,872	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

33.38%

Inst. Shares: 24,133,565

Shares Outstanding: 72,299,440

2025-12-31

44.41%

Inst. Shares: 23,194,783

Shares Outstanding: 52,228,068

2025-09-30

41.82%

Inst. Shares: 25,030,518

Shares Outstanding: 59,848,325

2025-06-30

70.13%

Inst. Shares: 28,495,060

Shares Outstanding: 40,630,403

2025-03-31

56.88%

Inst. Shares: 20,835,066

Shares Outstanding: 36,627,148

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	24,133,565	72,299,440	33.38%
2025-12-31	23,194,783	52,228,068	44.41%
2025-09-30	25,030,518	59,848,325	41.82%
2025-06-30	28,495,060	40,630,403	70.13%
2025-03-31	20,835,066	36,627,148	56.88%
2024-12-31	22,680,908	36,105,671	62.82%
2024-09-30	23,093,250	36,220,736	63.76%
2024-06-30	23,073,093	36,043,561	64.01%
2024-03-31	30,812,830	35,890,370	85.85%
2023-12-31	27,481,593	34,106,923	80.57%
2023-09-30	29,753,493	35,653,988	83.45%
2023-06-30	29,402,707	35,348,293	83.18%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Biomea Fusion, Inc. (BMEA) — SEC Financial Statements & Analysis

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.